STOCK TITAN

Cadre Holdings, Inc. (CDRE) SEC Filings, Nov-Dec 2025

CDRE NYSE

Cadre Holdings, Inc. SEC filings document the company's safety-equipment business, public-company governance and NYSE-listed common stock. Form 8-K reports cover operating results, financial condition, Regulation FD presentations, material events and related exhibits for its law enforcement, first responder, military and nuclear safety markets.

Cadre's filings also include proxy materials for annual meeting matters, board and stockholder voting procedures, and corporate governance disclosures. Financial-result filings discuss GAAP measures alongside non-GAAP metrics such as EBITDA, adjusted EBITDA and adjusted EBITDA margin, while event reports address material agreements, acquisition-related communications, capital-structure disclosures and security registration details for CDRE common stock.

Rhea-AI Summary

Cadre Holdings, Inc. insider Warren B. Kanders, who serves as CEO, Chairman, director and a 10% owner, reported a charitable stock gift. On 12/24/2025, he transferred 12,250 shares of Cadre common stock as a gift at a reported price of $0, moving the shares from his indirect holdings through Kanders SAF, LLC to a qualified charitable organization.

After this transaction, Kanders reported indirect beneficial ownership of 10,117,039 shares through Kanders SAF, LLC, as well as additional indirect holdings of 1,305,650 shares through a Warren B. Kanders Roth IRA and 23,450 shares through an Allison Kanders Roth IRA. He disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cadre Holdings' chief financial officer Blaine Browers reported selling 20,435 shares of common stock on 12/12/2025 at a weighted average price of $43.79 per share. After this transaction, he directly beneficially owned 63,142 shares of Cadre Holdings common stock.

The sale was reported as a single transaction in the filing, with shares sold in multiple trades at prices ranging from $43.41 to $44.31 per share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

An affiliate of CDRE has filed a Form 144 notice to sell up to 20,435 shares of common stock through UBS Financial Services Inc.. The planned sale, listed for execution on or about 12/12/2025 on the NYSE, has an indicated aggregate market value of $899,140. The shares were originally acquired as restricted stock units (RSUs) from the issuer on 03/18/2022. The filing also notes that there were 40,663,844 shares of this class outstanding at the time referenced, providing context for the size of the proposed transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Cadre Holdings, Inc. president Brad Williams reported a sale of company stock. On 12/10/2025, he sold 24,000 shares of Cadre Holdings common stock in an open-market transaction. The weighted average sale price was $42.99 per share, with individual trades executed between $41.84 and $43.39 per share. After this transaction, Williams beneficially owns 54,719 shares of Cadre Holdings common stock, held directly.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Cadre Holdings insider files to sell additional shares under Rule 144. A holder plans to sell 24,000 shares of Cadre Holdings common stock through UBS Financial Services on the NYSE, with an aggregate market value of approximately $1,031,309.14. These shares were acquired as restricted stock units from the issuer on March 18, 2024.

As context, 40,663,844 shares of Cadre Holdings common stock were outstanding at the time of this notice. Over the past three months, the same seller completed multiple open-market sales, including a 27,370‑share transaction on November 13, 2025 that generated gross proceeds of $1,193,840. The seller represents that they are not aware of any undisclosed material adverse information about the company’s current or prospective operations.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Cadre Holdings (CDRE) received an updated Schedule 13D from major shareholder Warren B. Kanders, reflecting recent trades and his current stake. He now beneficially owns 11,692,570 shares of common stock, representing about 27.7% of the company. This total includes shares held directly, in his Roth IRA, through Kanders SAF, LLC, options to purchase 232,635 shares that are exercisable within 60 days, and 23,450 shares held in his wife’s Roth IRA. It excludes additional stock options and restricted stock units that are not yet exercisable or vested.

The ownership percentage is calculated using 42,245,528 shares deemed outstanding, including certain vested awards and in-the-money options. On November 17, 2025, Kanders sold 1,257,038 shares and Kanders SAF sold 86,903 shares of Cadre Holdings common stock in a Rule 144 block trade at $39.00 per share. Of the shares beneficially owned, a total of 3,750,000 shares have been pledged as collateral in favor of Texas Capital Bank under an existing loan agreement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
other
Rhea-AI Summary

Cadre Holdings, Inc. (CDRE) CEO and Chairman Warren B. Kanders reported significant stock sales. On 11/17/2025, he sold 1,257,038 shares of Cadre common stock at $39 per share in a direct transaction, leaving him with 1,546 directly held shares. He also reported an indirect sale of 86,903 shares at $39 per share through Kanders SAF, LLC, after which that entity held 10,129,289 shares indirectly for him.

In addition, Kanders reported indirect beneficial ownership of 1,305,650 shares held in the Warren B. Kanders Roth IRA and 23,450 shares held in the Allison Kanders Roth IRA. He is listed as a director, 10% owner, and CEO and Chairman, and disclaims beneficial ownership of certain indirect holdings except to the extent of his pecuniary interest.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.23%
Tags
insider
-
Rhea-AI Summary

Cadre Holdings (CDRE) filed a Form 144 notice for the proposed sale of 1,343,941 common shares through broker Merrill Lynch on the NYSE, with an approximate sale date of 11/17/2025.

The shares listed have an aggregate market value of $56,566,477 based on the filing data. The filing reports that 40,663,844 shares of the issuer’s common stock are outstanding, providing context for the size of the potential sale.

The securities to be sold include shares acquired on 12/07/2021 via a liquidating distribution and shares acquired on 11/10/2025 upon the vesting and settlement of restricted stock units under the issuer’s 2021 Stock Incentive Plan.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Cadre Holdings, Inc. (CDRE) reported an insider stock sale by its President. According to the filing, the officer sold 27,370 shares of common stock on 11/13/2025 in an open-market transaction coded "S" (sale) at a weighted average price of $43.62 per share.

After this transaction, the reporting person beneficially owned 78,719 shares of Cadre Holdings common stock. The shares were sold in multiple trades within a price range of $43.50 to $43.82 per share, and detailed trade-by-trade information is available upon request as noted in the footnote.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

A shareholder of Cadre Holdings (CDRE) has filed a Form 144 notice to sell 27,370 shares of common stock through a broker, with an indicated aggregate market value of 1,193,605. The shares are of a class that had 40,663,844 shares outstanding and the proposed sale is targeted around 11/13/2025 on the NYSE.

The securities to be sold were acquired from the issuer via several restricted stock unit (RSU) awards on 03/09/2024, 03/13/2024, 03/18/2024, and 03/13/2025, totaling multiple RSU grants. The filing also notes that Brad Williams has sold blocks of 4,132 shares of common stock on 09/23/2025, 10/14/2025, and 10/24/2025, for gross proceeds of 152,754, 165,150, and 177,546, respectively.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other

FAQ

How many Cadre Holdings (CDRE) SEC filings are available on StockTitan?

StockTitan tracks 77 SEC filings for Cadre Holdings (CDRE), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Cadre Holdings (CDRE)?

The most recent SEC filing for Cadre Holdings (CDRE) was filed on December 29, 2025.